Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances ; volume:15 ; number:1 ; day:29 ; month:5 ; year:2020 ; pages:1-22 ; date:12.2020
Molecular neurodegeneration ; 15, Heft 1 (29.5.2020), 1-22, 12.2020
- Urheber
-
Wang, Wenzhang
Zhao, Fanpeng
Ma, Xiaopin
Perry, George
Zhu, Xiongwei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-020-00376-6
- URN
-
urn:nbn:de:101:1-2020080214290785667587
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Wenzhang
- Zhao, Fanpeng
- Ma, Xiaopin
- Perry, George
- Zhu, Xiongwei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease
Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
Complement in the pathogenesis of Alzheimer’s disease
Advances in Alzheimer’s Disease Drug Development
Innate immunity and inflammation in Alzheimer´s disease pathogenesis
Dysfunction of NMDA receptors in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
Correction to: Complement in the pathogenesis of Alzheimer’s disease
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease
Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
Complement in the pathogenesis of Alzheimer’s disease
Advances in Alzheimer’s Disease Drug Development
Innate immunity and inflammation in Alzheimer´s disease pathogenesis
Dysfunction of NMDA receptors in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
Correction to: Complement in the pathogenesis of Alzheimer’s disease
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease
Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
Complement in the pathogenesis of Alzheimer’s disease
Advances in Alzheimer’s Disease Drug Development
Innate immunity and inflammation in Alzheimer´s disease pathogenesis
Dysfunction of NMDA receptors in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation